Lightlake Therapeutics, Inc. Secures Distinguished Executive as Chairman
LLTP attaches valuable asset to Executive StaffLondon, ENGLAND – November 29, 2010 – Lightlake Therapeutics, Inc. (OTCBB: LLTP), announces today that the company has secured seasoned healthcare executive Dr. Michael Sinclair to serve as its Executive Chairman. Dr. Sinclair will be instrumental in developing financing options but will be primarily leading the board of directors in strategy and business development. Michael Sinclair qualified as a physician in 1967 and specialized in Psychiatry. In 1971 he founded Nestor Plc which grew to become at the time, the UK’s largest domiciliary